Proton MR Spectroscopy of Pediatric Brain Disorders
Open Access
- 14 June 2022
- journal article
- review article
- Published by MDPI AG in Diagnostics
- Vol. 12 (6) , 1462
Abstract
In vivo MR spectroscopy is a non -invasive methodology that provides information about the biochemistry of tissues. It is available as a “push-button” application on state-of-the-art clinical MR scanners. MR spectroscopy has been used to study various brain diseases including tumors, stroke, trauma, degenerative disorders, epilepsy/seizures, inborn errors, neuropsychiatric disorders, and others. The purpose of this review is to provide an overview of MR spectroscopy findings in the pediatric population and its clinical use.Keywords
This publication has 124 references indexed in Scilit:
- Elevated citrate in pediatric astrocytomas with malignant progressionNeuro-Oncology, 2011
- Is prenatal myo‐inositol deficiency a mechanism of CNS injury in galactosemia?Journal of Inherited Metabolic Disease, 2011
- Clinical Spectrum and Prognostic Factors of Acute Necrotizing Encephalopathy in ChildrenJournal of Korean Medical Science, 2010
- Magnetic resonance spectroscopy in the assessment of pilocytic astrocytomasEuropean Journal of Cancer, 2008
- Metabolism of diffuse intrinsic brainstem gliomas in childrenNeuro-Oncology, 2008
- Proton magnetic resonance spectroscopy and diffusion-weighted imaging in intracranial cystic mass lesionsSurgical Neurology, 2007
- N-Acetylaspartate in the CNS: From neurodiagnostics to neurobiologyProgress in Neurobiology, 2007
- Patterns of brain injury in term neonatal encephalopathyThe Journal of Pediatrics, 2005
- Detection of elevated glutathione in meningiomas by quantitative in vivo1H MRSMagnetic Resonance in Medicine, 2003
- Proton magnetic resonance spectroscopy for detection of axonal injury in the splenium of the corpus callosum of brain-injured patientsJournal of Neurosurgery, 1998